Bal Pharma Limited (BOM:524824)
India flag India · Delayed Price · Currency is INR
71.86
+2.06 (2.95%)
At close: Mar 10, 2026

Bal Pharma Company Description

Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.

The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs.

It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; herbal liver protective and antioxidant; and cardiac care products under the Secremet and Servace brands.

In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments.

Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation.

The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Bal Pharma Limited
Country India
Founded 1987
Industry Pharmaceutical Preparations
Employees 986
CEO Shailesh Siroya

Contact Details

Address:
Lakshmi Narayan Complex
Bengaluru, Karnataka 560052
India
Phone 91 80 4137 9500
Website balpharma.com

Stock Details

Ticker Symbol 524824
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Shailesh Siroya Chief Executive Officer
Daddanala Bharath Bhushan Chief Financial Officer
Archana Mitra Chief Operating Officer